ptcy in unrelated and haploidentical donor allohsct in cml
Published 2 years ago • 40 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
2:13
haploidentical sct for the treatment of secondary aml
-
3:54
impact of donor kinship on outcome of haplohct with ptcy in acute leukemias
-
1:15
the diagnosis and management of mds/mpn with neutrophilia (atypical cml)
-
2:00
hhv-6 reactivation after haploidentical transplantation with ptcy & atg: incidence and risk factors
-
8:40
investigating pp2a-based therapeutic strategies for kmt2a-rearranged acute leukemia
-
1:37
long-term follow-up from a phase ii trial of olutasidenib in idh1-mutated aml
-
2:52
gvhd prophylaxis in aml: ptcy versus cni
-
1:23:21
alterations in hematological function part 1- rn pathophysiology
-
1:04:31
advanced haemodynamic monitoring and tee
-
1:06:04
itp: novel treatments
-
2:03
relapse incidence post-allosct with ptcy for aml in cr1
-
0:52
highlights from icle 2022
-
2:33
dli following haplohct ptcy relapse
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
2:18
advice for hcps wanting to get into hematology clinical trials
-
2:29
unmet clinical needs in bpdcn: improving diagnosis and treatment approaches
-
2:52
novel prognostic score for cmml patients undergoing sct
-
2:29
the role of the multidisciplinary team in providing adequate diagnosis & treatment for bpdcn
-
1:24
signal-omics to fingerprint the impact of antigen engagement in cll
-
3:29
ptcy as gvhd prophylaxis: side effects, optimizing the dose, and the effect of dose-reduction
-
1:56
ongoing and future trials in mpn-ap/bp